University to Study Genetics Role in Vaccine Response

Article

The University of Alabama at Birmingham (UAB) has received a five-year, $12 million contract from the National Institute of Allergy and Infectious Diseases to study genetic factors that influence how well individuals respond to the anthrax vaccine.

 

This research will provide valuable information about individual differences in immune response and in adverse reactions to the anthrax vaccine, says Richard Kaslow, MD, professor of epidemiology in the School of Public Health at UAB.

 

The investigation will rely heavily on information gathered from an ongoing study of the anthrax vaccine under way at several medical research institutions, including UAB.

 

Hopefully, our work will give us greater insight into the way the vaccine works and the role of genetics in determining response, Kaslow adds.

 

Source: University of Alabama at Birmingham    

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content